FDA Drug Application (017796) for BRYREL by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number017796
Product Number001
FormSYRUP;ORAL
DosageEQ 500MG BASE/5ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBRYREL
Active IngredientPIPERAZINE CITRATE

Active IngredientCount
List of drugs with Active Ingredient PIPERAZINE CITRATE5


Back to FDA Applications sponsored by SANOFI AVENTIS US